Transcriptional antagonism by CDK8 inhibition improves therapeutic efficacy of MEK inhibitors

被引：0
|
作者：
Malone, Clare F. [1 ]
Kim, Minjee [1 ]
Alexe, Gabriela [1 ]
Forman, Alexandra B. [1 ]
Robichaud, Amanda [1 ]
Conway, Amy Saur [1 ]
Goodale, Amy [2 ]
Hatcher, John M. [1 ]
Gray, Nathanael S. [3 ]
Piccioni, Federica [2 ]
Stegmaier, Kimberly [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Broad Inst, Cambridge, MA USA
[3] Stanford Univ, Stanford, CA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2010
引用
收藏
页数：2
相关论文
共 50 条
  • [21] CDK8 is a positive regulator of transcriptional elongation within the serum response network
    Aaron J Donner
    Christopher C Ebmeier
    Dylan J Taatjes
    Joaquín M Espinosa
    Nature Structural & Molecular Biology, 2010, 17 : 194 - 201
  • [22] Studies of CDK 8/19 inhibitors: Discovery of novel and selective CDK8/19 dual inhibitors and elimination of their CYP3A4 time-dependent inhibition potential
    Fujimoto, Jun
    Hirayama, Takaharu
    Hirata, Yasuhiro
    Hikichi, Yukiko
    Murai, Saomi
    Hasegawa, Maki
    Hasegawa, Yuka
    Yonemori, Kazuko
    Hata, Akito
    Aoyama, Kazunobu
    Cary, Douglas R.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (12) : 3018 - 3033
  • [23] Discovery of preclinical development candidate inhibitors of the mediator complex-associated kinases CDK8 and CDK19 and evaluation of their therapeutic potential
    Clarke, Paul
    Esdar, Christina
    Mallinger, Aurelie
    Schiemann, Kai
    Waalboer, Dennis
    Crumpler, Simon
    Rink, Christian
    Stieber, Frank
    Calderini, Michel
    Adeniji-Popoola, Olajumoke
    Ortiz-Ruiz, Maria-Jesus
    Samant, Rahul S.
    Czodrowski, Paul
    Musil, Djordje
    Schwarz, Daniel
    Schneider, Klaus
    Busch, Michael
    Stubbs, Mark
    Burke, Rosemary
    TePoele, Robert
    Gowan, Sharon
    Rohdich, Felix
    Raynaud, Florence
    Schneider, Richard
    Poeschke, Oliver
    Blaukat, Andree
    Urbahns, Klaus
    Workman, Paul
    Kaufmann, Wolfgang
    Simon, Stephanie
    Eccles, Suzanne A.
    Dale, Trevor
    Wienke, Dirk
    Blagg, Julian
    CANCER RESEARCH, 2016, 76
  • [24] Combination JAK1/2 and CDK8/19 inhibition demonstrates enhanced efficacy in myeloproliferative neoplasms
    Zaroogian, Zachary
    Adamczyk, Elzbieta
    Moszynska, Adrianna
    Obacz, Marta
    Pakulska, Urszula
    Durham, Benjamin
    Mazan, Milena
    Mowla, Shoron
    Wnek, Katarzyna
    Somasundara, Amritha Varshini Hanasoge
    Barczuk, Beata
    Golas, Aniela
    Levine, Ross
    Rzymski, Tomasz
    Rampal, Raajit
    CANCER RESEARCH, 2024, 84 (06)
  • [25] CDK8 is a positive regulator of transcriptional elongation within the serum response network.
    Espinosa, Joaquin M.
    Donner, Aaron J.
    Galbraith, Matthew
    Taatjes, Dylan
    Ebmeier, Chris
    FASEB JOURNAL, 2010, 24
  • [26] Biomarker Discovery for TNBC and CRC Tumor Sensitivity to Novel CDK8 Inhibitors
    Spear, Jensen-Marie
    Russu, Wade
    FASEB JOURNAL, 2020, 34
  • [27] Novel potent and selective orally available CDK8/19 kinase inhibitors
    Aparicio, Carmen Blanco
    Renner, Oliver
    Gomez-Casero, Elena
    Albarran, Maria Isabel
    Cebria, Antonio
    Barrera, Borja
    Aguirre, Enara
    de Miguel, Maria del Carmen Rodriguez
    Urbana, Manuel
    Hernandez, Ana Isabel
    de la Oliva, Cristina Gomez
    Rivero, Virginia
    Riesco, Rosario Concepcion
    Gonzalez, Sonia Martinez
    Pastor, Joaquin
    CANCER RESEARCH, 2016, 76
  • [28] Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8
    Bergeron, Philippe
    Koehler, Michael F. T.
    Blackwood, Elizabeth M.
    Bowman, Krista
    Clark, Kevin
    Firestein, Ron
    Kiefer, James R.
    Maskos, Klaus
    McCleland, Mark L.
    Orren, Linda
    Ramaswamy, Sreemathy
    Salphati, Laurent
    Schmidt, Steve
    Schneider, Elisabeth V.
    Wu, Jiansheng
    Beresini, Maureen
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (06): : 595 - 600
  • [29] Discovery of novel and potent CDK8 inhibitors for the treatment of acute myeloid leukaemia
    Chen, Zhuoying
    Wang, Quan
    Yan, Yao Yao
    Jin, Dalong
    Wang, Yumeng
    Zhang, Xing Xing
    Liu, Xin Hua
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2024, 39 (01)
  • [30] A kinase subunit of the human mediator complex, CDK8, positively regulates transcriptional activation
    Furumoto, Tadashi
    Tanaka, Aki
    Ito, Mitsuhiro
    Malik, Sohail
    Hirose, Yutaka
    Hanaoka, Fumio
    Ohkuma, Yoshiaki
    GENES TO CELLS, 2007, 12 (01) : 119 - 132
12345